Dual Beneficial Effects of (-)-Epigallocatechin-3-Gallate on Levodopa Methylation and Hippocampal Neurodegeneration: In Vitro and In Vivo Studies-Reference-Cited by-同舟云学术

Dual Beneficial Effects of (-)-Epigallocatechin-3-Gallate on Levodopa Methylation and Hippocampal Neurodegeneration: In Vitro and In Vivo Studies

Published:2010-08-05 Issue:8 Volume:5 Page:e11951
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Kang Ki Sung,Wen Yujing,Yamabe Noriko,Fukui Masayuki,Bishop Stephanie C.,Zhu Bao Ting

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference65 articles.

1. Description of Parkinson's disease as a clinical syndrome.;S Fahn;Ann NY Acad Sci,2003

2. Progress in Parkinson's disease-Where do we stand?;A Toulouse;Prog Neurobiol,2008

3. Emerging drugs for Parkinson's disease.;JC Morgan;Expert Opin Emer Drugs,2006

4. The place of COMT inhibitors in the armamentarium of drugs for the treatment of Parkinson's disease.;AH Schapira;Neurology,2000

5. Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology and clinical efficacy of the new selective COMT inhibitors.;PT Mannisto;Pharmacol Rev,1999

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epigallokateşin Gallatın (EGCG) Parkinson Hastalığı Patogenezinde Potansiyel Koruyucu Etkileri;Bandırma Onyedi Eylül Üniversitesi Sağlık Bilimleri ve Araştırmaları Dergisi;2024-08-22

2. Neurodegenerative diseases and catechins: (−)-epigallocatechin-3-gallate is a modulator of chronic neuroinflammation and oxidative stress;Frontiers in Nutrition;2024-08-01

3. Clinically proven natural products in aid of treating Parkinson's disease: a comprehensive review;Current Medicine;2024-06-13

4. Effects of plant extracts and derivatives on cardiac K ⁺ , Nav, and Ca _v channels: a review;Natural Product Research;2024-04-08

5. A neoteric annotation on the advances in combination therapy for Parkinson’s disease: nanocarrier-based combination approach and future anticipation. Part I: exploring theoretical insights and pharmacological advances;Expert Opinion on Drug Delivery;2024-03-03